Fact CheckerSign in

NCT07226843RecruitingPhase 1

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

NOVA-BCL6-1, A First-in-Human, Multicenter Phase 1a/1b Study to Investigate Safety, Tolerability, Pharmacokinetics, and Efficacy of LY4584180 in Adult Participants With Previously Treated Hematologic Malignancies

Source: ClinicalTrials.gov · Last updated 4 Nov 2026

Brief summary (registry, in English)

The main purpose of this study is to evaluate safety and efficacy, and measure how much LY4584180 gets into the bloodstream and how long it takes the body to eliminate it in patients with previously treated blood cancers. For each participant, the study could last about 9 months or possibly longer including screening.

Status (registry)
Recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
460 (estimated)
First submitted
7 Nov 2025
Start date
17 Apr 2026
Primary completion date
Sept 2028
Lead sponsor
Eli Lilly and Company
NCT number
NCT07226843
EU CT number
2025-523601-16-00

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 460
  • From 17 Apr 2026 to the primary completion date, Sept 2028
  • 45 sites in 8 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Has known central nervous system (CNS) involvement by systemic lymphoma. Patients with previous treatment for CNS involvement who are neurologically stable and without evidence of active CNS disease may be eligible and enrolled if a compelling clinical rationale is provided by the Investigator and with documented Sponsor approval.

Other illness

  • Has an active second cancer
  • Has known Cytomegalovirus infection. Participants with negative status are eligible
  • Has known hepatitis B or C infection or uncontrolled HIV
  • Has known significant heart disease

Who the study is looking for

  • Has been treated for the following blood cancers and has received at least 2 prior lines of systemic therapy or not eligible for available therapy:
    • Diffuse large B-cell lymphoma - not otherwise specified
    • High-grade B-cell lymphoma
    • Diffuse large B-cell lymphoma - transformed from indolent lymphomas
    • Follicular large B-cell lymphoma
    • Follicular lymphoma
    • Other non-Hodgkin lymphoma
  • Has measurable disease
  • Has discontinued all previous treatments for cancer and has recovered from the immediate effects of therapy

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (45)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universitaetsklinikum Koeln AöR
Coordinator of this site? Confirm its status
CologneGermanyNot yet recruiting
Universitaetsklinikum Essen (AoR)
Coordinator of this site? Confirm its status
EssenGermanyNot yet recruiting
Goethe University Frankfurt
Coordinator of this site? Confirm its status
Frankfurt Am MainGermanyNot yet recruiting
Institut Catala D'oncologia
Coordinator of this site? Confirm its status
L'Hospitalet de LlobregatSpainNot yet recruiting
Hospital Universitario Fundación Jiménez Díaz
Coordinator of this site? Confirm its status
MadridSpainNot yet recruiting
Centre Hospitalier Universitaire de Nantes
Coordinator of this site? Confirm its status
NantesFranceWithdrawn
Institut Curie
Coordinator of this site? Confirm its status
ParisFranceWithdrawn
Centre Hospitalier Universitaire de Bordeaux
Coordinator of this site? Confirm its status
PessacFranceWithdrawn
Hospices Civils de Lyon
Coordinator of this site? Confirm its status
Pierre-BéniteFranceWithdrawn
Oncopole Claudius Regaud
Coordinator of this site? Confirm its status
Toulouse Cedex 9FranceWithdrawn
The Royal Marsden NHS Foundation Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomNot yet recruiting
King's College Hospital
Coordinator of this site? Confirm its status
LondonUnited KingdomNot yet recruiting
Nottingham City Hospital
Coordinator of this site? Confirm its status
NottinghamUnited KingdomNot yet recruiting
Derriford Hospital
Coordinator of this site? Confirm its status
PlymouthUnited KingdomNot yet recruiting
University Hospital Southampton NHS Foundation Trust
Coordinator of this site? Confirm its status
SouthamptonUnited KingdomNot yet recruiting
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Coordinator of this site? Confirm its status
BolognaItalyNot yet recruiting
Istituto Europeo di Oncologia s.r.l
Coordinator of this site? Confirm its status
MilanItalyNot yet recruiting
National Cancer Center Hospital East
Coordinator of this site? Confirm its status
ChibaJapanNot yet recruiting
Okayama University Hospital
Coordinator of this site? Confirm its status
OkayamaJapanRecruiting
Cancer Institute Hospital of JFCR
Coordinator of this site? Confirm its status
TokyoJapanRecruiting
Pratia S.A.
Coordinator of this site? Confirm its status
CracowPolandNot yet recruiting
Pratia Hematologia Sp. Z o. o
Coordinator of this site? Confirm its status
KatowicePolandNot yet recruiting
Aidport sp z o.o.
Coordinator of this site? Confirm its status
SkorzewoPolandNot yet recruiting
Instytut Hematologii I Transfuzjologii
Coordinator of this site? Confirm its status
WarsawPolandNot yet recruiting
Emory University Hospital
Coordinator of this site? Confirm its status
AtlantaUnited StatesRecruiting
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
The Ohio State University (OSU)
Coordinator of this site? Confirm its status
ColumbusUnited StatesRecruiting
Texas Oncology - DFW (Sammons CC)
Coordinator of this site? Confirm its status
DallasUnited StatesRecruiting
Colorado Blood Cancer Institute
Coordinator of this site? Confirm its status
DenverUnited StatesRecruiting
City of Hope
Coordinator of this site? Confirm its status
DuarteUnited StatesRecruiting
Baylor College of Medicine
Coordinator of this site? Confirm its status
HoustonUnited StatesNot yet recruiting
University of California, Los Angeles (UCLA) - Medical Center
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting
University of Miami - Sylvester Cancer Center
Coordinator of this site? Confirm its status
MiamiUnited StatesRecruiting
Froedtert Hospital and the Medical College of Wisconsin
Coordinator of this site? Confirm its status
MilwaukeeUnited StatesRecruiting
Vanderbilt University Medical Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesRecruiting
Sarah Cannon Research Institute
Coordinator of this site? Confirm its status
NashvilleUnited StatesRecruiting
Columbia University
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
Oregon Health & Science University (OHSU)
Coordinator of this site? Confirm its status
PortlandUnited StatesNot yet recruiting
University of Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesRecruiting
Mayo Clinic - Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesRecruiting
University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center
Coordinator of this site? Confirm its status
San FranciscoUnited StatesRecruiting
Florida Cancer Specialists - Sarasota
Coordinator of this site? Confirm its status
SarasotaUnited StatesRecruiting
Mayo Clinic Scottsdale
Coordinator of this site? Confirm its status
ScottsdaleUnited StatesRecruiting
University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance)
Coordinator of this site? Confirm its status
SeattleUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.